KiddeFenwal Launches NATURA™ Micro, Offering Enhanced, Compact Object Fire Protection for Vital Commercial and Industrial Assets January 16, 2026 Unveiling coincides with the introduction of sound- and vibration-dampening acoustic nozzles and additional NATURA™ “total flood” inert gas system enhancements at Intersec
Announcement Regarding the Launch of an Open-Ended Aircraft Fund January 16, 2026 – Providing investors with a more liquid aircraft investment opportunity, a new frontier in alternative investments – – The first initiative of its kind by a Japan-based asset manager –
Terra Firma Energy – UK CfD Auction Clears at Higher Wind Prices — Underscoring the Value of Firm, Flexible Generation to Keep Bills Down and the Lights On January 16, 2026 The UK’s latest Contracts for Difference (CfD) Allocation Round results confirm a major step forward for clean electricity buildout, while also highlighting a simple truth about power system economics: as wind and solar scale, flexible, dispatchable capacity becomes more valuable and, done well, cheaper for consumers than the alternatives. This press release features multimedia. View [...]
AWS Launches AWS European Sovereign Cloud and Announces Expansion Across Europe January 16, 2026 AWS announces the general availability of the AWS European Sovereign Cloud and plans to expand across Europe with new AWS Local Zones in Belgium, the Netherlands, and Portugal Amazon plans to invest more than €7.8 billion in the AWS European Sovereign Cloud in Germany and support an average of 2,800 full-time equivalent jobs annually
Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema January 16, 2026 Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a potentially promising therapeutic option. LumiNE is part of Almirall’s ongoing lifecycle management activities to enable more patients to benefit from advanced treatments - such as Lebrikizumab - targeting patients with dermatological conditions and high unmet medical needs. The phase III study will be initiated within the first half of 2026 and will evaluate the efficacy, safety, and tolerability of lebrikizumab in at least 270 patients with nummular eczema in Europe for up to 48 weeks of treatment.
Northern Trust Asset Management Forecasts AI-Driven Strength in Private Markets; United States, Japan and Australia to Lead Equity Returns over Next Decade January 16, 2026 AI innovation, the global shift to self-reliance and rising government debt likely to be key drivers of financial markets
Gravity Doesn’t Stand A Chance January 16, 2026 Rimmel London & Red Bull Deliver Gravity Defying Lashes & Thrilling Beam Routine Stunt Beauty brand Rimmel London has joined forces with Red Bull to launch the new Rimmel Thrill Seeker Mega Lift Mascara, taking a collegiate athlete to new heights with lashes lifted from every angle. In Red Bull’s first partnership with Rimmel London, Lily Smith takes on the gravity-defying challenge with confidence and style, and lashes as bold as her routine. The beautifully bold gymnastic balance beam routine was set 52 stories above the streets, which gave Red Bull gymnast Lily Smith wings to reach new heights!
Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities January 16, 2026 Continued expansion of the firm’s Venture Growth Evergreen platform
Rapyd’s 2026 State of Stablecoins: Businesses Move En Masse as Stablecoins Go Mainstream January 16, 2026 Rapyd’s 2026 State of Stablecoins Report shows 64% of businesses surveyed already use stablecoins or plan to within three years, with speed, easier cross-border transactions, and cost savings driving adoption
Everest Appoints Christopher Kujawa as Executive Vice President and Chief Human Resources Officer January 16, 2026 Everest Group, Ltd. (NYSE: EG), a global underwriting leader providing world-class reinsurance and specialty insurance solutions, announced today that Christopher Kujawa has been appointed Executive Vice President and Chief Human Resources Officer, effective January 20, 2026. Mr. Kujawa will report to Jim Williamson, President and CEO and will serve on Everest’s Executive Leadership Team. He [...]